Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2000 Mar 15;25(4):282-4.
doi: 10.1016/s0212-6567(00)78503-9.

[Decrease in mortality on spironolactone being added to the conventional treatment of heart failure]

[Article in Spanish]
J Soto Alvarez
Comment

[Decrease in mortality on spironolactone being added to the conventional treatment of heart failure]

[Article in Spanish]
J Soto Alvarez. Aten Primaria. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. López-Rodríguez I., Castro-Beiras A., Asensi A., Bacariza F., Rábade J.M., Núñez J. Normas básicas de manejo de la insuficiencia cardíaca en atención primaria. Aten Primaria. 1999;24:289–294. - PubMed
    1. Weber K.T. Aldosterone and spironolactone in heart failure. N Engl J Med. 1999;341:753–754. - PubMed
    1. The Rales Investigators Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (the Randomized Aldactone Evaluation Study [RALES]) Am J Cardiol. 1996;78:902–907. - PubMed
    1. Pitt B., Zannad F., Remme W.J., Cody R., Castaigne A., Pérez A. The effect of spironolactone on morbidity and mortality in patients with severe hearyt failure. N Engl J Med. 1999;341:709–717. - PubMed
    1. Brotons C., Moral I., Ribera A., Pérez G., Cascant P., Bastius M., Permanyer-Miralda G. Tendencias de la morbimortalidad por insuficiencia cardíaca en Cataluña. Rev Esp Cardiol. 1998;51:972–976. - PubMed